eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader
30 mai 2023 16h06 HE
|
EUREKARE
Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company’s unique offer...
eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de la bio-CDMO
30 mai 2023 16h06 HE
|
EUREKARE
eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de...
(SPAC) Special Purpose Acquisition Investigation: BBAI, TNGX, SNTI, GMTX, Contact Shareholder Rights Law Firm Johnson Fistel
26 mai 2023 12h26 HE
|
Johnson Fistel, LLP
SAN DIEGO, May 26, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition...
(SPAC) Special Purpose Acquisition Investigation: PWP, PRCH, VCSA, SKIL - Contact Shareholder Rights Law Firm Johnson Fistel
25 mai 2023 12h06 HE
|
Johnson Fistel, LLP
SAN DIEGO, May 25, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition...
Newsight Imaging CEO Eli Assoolin Featured in Bell2Bell Audio Production
17 mai 2023 08h30 HE
|
Newsight Imaging Ltd.
NESS ZIONA, Israel, May 17, 2023 (GLOBE NEWSWIRE) -- via IBN -- Newsight Imaging Ltd. (“Newsight”), a leading semiconductor innovator developing proprietary 3D machine vision sensors, spectral...
enGene, Inc. and Forbion European Acquisition Corp. (“FEAC”, Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies
17 mai 2023 07h00 HE
|
Forbion
Leading institutional investors commit $135 million USD in transaction financing, anchored by FEAC’s sponsor, Forbion Growth Sponsor FEAC I B.V. (together with its parent entity Forbion Growth...
(SPAC) Special Purpose Acquisition Investigation: DOMA, CYXT, Contact Shareholder Rights Law Firm Johnson Fistel
15 mai 2023 09h04 HE
|
Johnson Fistel, LLP
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition...
IX Acquisition Corp. Announces Second Extension of Deadline to Complete Initial Business Combination
09 mai 2023 20h05 HE
|
IX Acquisition Corp.
NEW YORK, May 10, 2023 (GLOBE NEWSWIRE) -- IX Acquisition Corp. (NASDAQ: IXAQU, IXAQA, IXAQUW) (“IXAQ” or the “Company”), announced today that its board of directors (the “Board”) has decided to...
(SPAC) Special Purpose Acquisition Investigation: PWP, PRCH, VCSA, SKIL - Contact Shareholder Rights Law Firm Johnson Fistel
02 mai 2023 09h26 HE
|
Johnson Fistel, LLP
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition...
(SPAC) Special Purpose Acquisition Investigation: BBAI, TNGX, SNTI, BOXD, Contact Shareholder Rights Law Firm Johnson Fistel
02 mai 2023 09h01 HE
|
Johnson Fistel, LLP
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition...